Summary & Overview
CPT 86688: HTLV II Antibody Immunoassay
CPT code 86688 represents a serologic immunoassay performed on patient serum to detect antibodies to human T-cell lymphotropic virus Type II (HTLV II). This laboratory diagnostic code is used in clinical and public health contexts where confirmation of HTLV II exposure or infection is indicated. Nationally, accurate coding for infectious disease serologies supports surveillance, patient management, and appropriate payer adjudication.
Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the clinical context for HTLV II antibody testing, common places where the service is provided, and the payer landscape typically involved in coverage and claims processing. The content outlines benchmarks and reference points for coding practice, reimbursement considerations, and coding accuracy issues that affect claim acceptance and clinical documentation.
This publication provides practical reference material: a concise code description, expected service settings, and the payer mix relevant to national billing and policy discussions. Data not available in the input are noted where applicable in supporting sections.
Billing Code Overview
CPT code 86688 describes an immunoassay for antibodies to human T-cell lymphotropic virus Type II (HTLV II) performed by a laboratory analyst on a patient’s serum. The service evaluates the patient’s serum for the presence of antibodies indicating exposure to HTLV II.
Service type: Laboratory diagnostic test — serologic immunoassay
Typical site of service: Clinical laboratory or hospital laboratory (ambulatory or inpatient specimen processing)
Clinical & Coding Specifications
Clinical Context
A 42-year-old patient presents to an outpatient infectious disease clinic with a history of unexplained lymphadenopathy, chronic dermatitis, and a recent reactive screening for human T-lymphotropic virus (HTLV) on initial serologic testing. The clinician orders confirmatory testing specifically for HTLV Type II to characterize seroreactivity and to guide counseling and epidemiologic reporting.
The clinical workflow begins with the clinician entering the laboratory order for 86688 in the electronic health record. A phlebotomy technician collects serum during the same visit or schedules a separate draw. The specimen is sent to the clinical immunology laboratory where a technologist performs an immunoassay targeted to detect antibodies to HTLV II. Results are reviewed by the laboratory director and reported in the patient chart. Positive or indeterminate results prompt reflex confirmatory testing per institutional protocol and communication to the ordering provider for patient counseling and potential public health reporting.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
11 | Professional component | Use when billing the physician or laboratorian's interpretive/professional component separately from the technical component. |